Methylprednisolone Recruiting Phase 4 Trials for Novel Coronavirus Infectious Disease (COVID-19) / 2019-nCoV Severe Pneumonia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04263402The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia